Zyklosporine

Patent europeic · EP0484281 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0484281
Numer da la dumonda
EP91810841
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Mantegnì en furma midada
Annunzià
30-10-1991
Publitgà
06-05-1992
Concedì
29-01-1997
Stritgà
29-10-2011
Motiv
Durada maximala cuntanschida
Classas IPC
C07K 7/64 (2006.01)
A61K 38/12 (2006.01)
C12P 21/04 (2006.01)
*C12P 21/04 (2006.01)
Prioritad
GB 9023859 02.11.1990
GB 9023972 05.11.1990
GB 9023970 05.11.1990
GB 9023971 05.11.1990
GB 9116836 05.08.1991
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 31-10-2011

    Durada maximala cuntanschida

    Published in Swissreg on 31.10.2011

  2. 15-12-2000

    Midada

    Published in PIDTJ No 23 in 2000

  3. 15-05-1997

    Adressa midada

    Owner
    SANDOZ LTD., Lichtstrasse 35, 4002 Basel → Novartis AG, Schwarzwaldallee 215, 4058 Basel

    Published in PIDTJ No 9 in 1997

  4. 31-01-1997

    Concedì

    Published in PIDTJ No 2 in 1997

Partidas

Possessur

Novartis AG

Schwarzwaldallee 215, 4058 Basel

Inventur

Ko, Soo Young

London NW3 4LY, GB

Kobel, Hans

CH-4059 Basle

Rosenwirth, Brigitte

A-2340 Mödling, AT

Seebach, Dieter

CH-8044 Zürich

Traber, René P.

CH-4052 Basle

Wenger, Roland

CH-4125 Riehen

Bollinger, Pietro

CH-4103 Bottmingen

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.